Used as an intermediate in the synthesis of kinase inhibitors, particularly in the development of pharmaceuticals targeting cancer and inflammatory diseases. Its structure allows for selective modification to produce active drug compounds, especially in the class of pyrrolopyrimidine-based therapeutics. Commonly employed in medicinal chemistry for constructing ATP-competitive inhibitors due to its ability to mimic purine scaffolds. Also utilized in research settings to develop compounds with antiproliferative activity.